ADVENTIA PHARMA launches 'Permeacare', a new product for increased intestinal permeability

10 de June de 2020

ADVENTIA PHARMA launches 'Permeacare', a new product for increased intestinal permeability

The Spanish pharmaceutical laboratory Adventia Pharma has launched 'Permeacare', a new product for increased intestinal permeability, directly related to different diseases, not only digestive, such as irritable bowel syndrome or inflammatory bowel disease, but also neurological, rheumatological or dermatological . The alteration of the intestinal wall allows toxic substances and microorganisms to cross the intestinal barrier and reach the ...

Read more https://www.infosalus.com/salud-investigacion/noticia-adventia-pharma-lanza-permacare-nuevo-producto-permeabilidad-intestinal-aumentada-20200610171547.html

For more information about our products, call us on the phone (+34) 928 223 717 or info@adventiapharma.com
Copyright © 2024 Adventia Pharma. Todos los derechos reservados.
magnifiercrosschevron-down